No Cover Image

Journal article 471 views 118 downloads

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes / David Owens, Geremia B. Bolli, Bernard Charbonnel, Thomas Haak, Wolfgang Landgraf, Francesca Porcellati, Louise Traylor, Alexandra Kautzky-Willer

Diabetes, Obesity and Metabolism, Volume: 19, Issue: 11, Pages: 1546 - 1554

Swansea University Author: David Owens

Check full text

DOI (Published version): 10.1111/dom.12966

Published in: Diabetes, Obesity and Metabolism
ISSN: 14628902
Published: 2017
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa33019
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2017-04-24T13:04:54Z
last_indexed 2018-02-09T05:21:35Z
id cronfa33019
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2017-10-17T16:01:16.2141190</datestamp><bib-version>v2</bib-version><id>33019</id><entry>2017-04-24</entry><title>Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100&#x2009;U/mL added to oral antidiabetes agents in type 2 diabetes</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-04-24</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>19</volume><journalNumber>11</journalNumber><paginationStart>1546</paginationStart><paginationEnd>1554</paginationEnd><publisher/><issnPrint>14628902</issnPrint><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-12-31</publishedDate><doi>10.1111/dom.12966</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-10-17T16:01:16.2141190</lastEdited><Created>2017-04-24T08:17:55.2574213</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>1</order></author><author><firstname>Geremia B.</firstname><surname>Bolli</surname><order>2</order></author><author><firstname>Bernard</firstname><surname>Charbonnel</surname><order>3</order></author><author><firstname>Thomas</firstname><surname>Haak</surname><order>4</order></author><author><firstname>Wolfgang</firstname><surname>Landgraf</surname><order>5</order></author><author><firstname>Francesca</firstname><surname>Porcellati</surname><order>6</order></author><author><firstname>Louise</firstname><surname>Traylor</surname><order>7</order></author><author><firstname>Alexandra</firstname><surname>Kautzky-Willer</surname><order>8</order></author></authors><documents><document><filename>0033019-24042017082126.pdf</filename><originalFilename>Owens2017.pdf</originalFilename><uploaded>2017-04-24T08:21:26.4070000</uploaded><type>Output</type><contentLength>1034417</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><action/><embargoDate>2018-07-27T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2017-10-17T16:01:16.2141190 v2 33019 2017-04-24 Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2017-04-24 BMS Journal Article Diabetes, Obesity and Metabolism 19 11 1546 1554 14628902 31 12 2017 2017-12-31 10.1111/dom.12966 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2017-10-17T16:01:16.2141190 2017-04-24T08:17:55.2574213 Swansea University Medical School Medicine David Owens 0000-0003-1002-1238 1 Geremia B. Bolli 2 Bernard Charbonnel 3 Thomas Haak 4 Wolfgang Landgraf 5 Francesca Porcellati 6 Louise Traylor 7 Alexandra Kautzky-Willer 8 0033019-24042017082126.pdf Owens2017.pdf 2017-04-24T08:21:26.4070000 Output 1034417 application/pdf Accepted Manuscript true 2018-07-27T00:00:00.0000000 true eng
title Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
spellingShingle Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
David, Owens
title_short Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
title_full Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
title_fullStr Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
title_full_unstemmed Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
title_sort Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
author_id_str_mv 2fd4b7c3f82c6d3bd546eff61ff944e9
author_id_fullname_str_mv 2fd4b7c3f82c6d3bd546eff61ff944e9_***_David, Owens
author David, Owens
author2 David Owens
Geremia B. Bolli
Bernard Charbonnel
Thomas Haak
Wolfgang Landgraf
Francesca Porcellati
Louise Traylor
Alexandra Kautzky-Willer
format Journal article
container_title Diabetes, Obesity and Metabolism
container_volume 19
container_issue 11
container_start_page 1546
publishDate 2017
institution Swansea University
issn 14628902
doi_str_mv 10.1111/dom.12966
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 1
active_str 0
published_date 2017-12-31T03:51:37Z
_version_ 1714558387178438656
score 10.830003